wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37598881-005FA244-3C02-4BC5-9D95-BBA771747120
Q37598881-005FA244-3C02-4BC5-9D95-BBA771747120
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37598881-005FA244-3C02-4BC5-9D95-BBA771747120
Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes.
P2860
Q37598881-005FA244-3C02-4BC5-9D95-BBA771747120
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37598881-005FA244-3C02-4BC5-9D95-BBA771747120
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
09df5ceb8a193c17ccdfbcec8ce6c4a59bec99fb
P2860
Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia).